| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/19/2003 | EP1283883A1 Treatment of cancer and neurological diseases |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283880A1 Antiviral antisense therapy |
| 02/19/2003 | EP1283879A2 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same |
| 02/19/2003 | EP1283878A2 Receptor-based interaction trap |
| 02/19/2003 | EP1283873A2 Site-selective acyl transfer |
| 02/19/2003 | EP1283872A2 Catalytically active peptides |
| 02/19/2003 | EP1283870A1 Novel cell systems having specific interaction of peptide binding pairs |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283868A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 02/19/2003 | EP1283851A2 Use of interleukin-4 antagonists and compositions thereof |
| 02/19/2003 | EP1283850A2 Thrombospondin type 1 repeat polypeptides |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283847A1 Pancreatic progenitor 1 gene and its uses |
| 02/19/2003 | EP1283846A2 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
| 02/19/2003 | EP1283718A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 02/19/2003 | EP1283716A1 Vaccine comprising a tick cement protein |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1283676A2 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings |
| 02/19/2003 | EP1283668A1 Nucleic acids that control plant development |
| 02/19/2003 | EP1206561B1 Method for production of proteinaceous substances |
| 02/19/2003 | EP1081159B1 Purified human activin and process for producing the same |
| 02/19/2003 | EP1056777A4 Ligand receptors and uses therefor |
| 02/19/2003 | EP0950065B1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 02/19/2003 | EP0758381B1 Biologically active eph family ligands |
| 02/19/2003 | EP0483304B1 Method of inactivation of viral and bacterial blood contaminants |
| 02/19/2003 | CN1398299A BZIP type transcripton factors regulating expression of rice storage protein |
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
| 02/19/2003 | CN1398188A Boltuminum toxin pharmaceutical compsns |
| 02/19/2003 | CN1398187A Method and compsns. for treating liver cell cancer |
| 02/19/2003 | CN1397647A Process for transforming antibacterial peptide AD gene by yeast fermentation |
| 02/19/2003 | CN1397643A Method for expressing modified human alpha antitrypsin gene in sheep's mammar gland |
| 02/19/2003 | CN1397641A Virus reproduced in tumor cell for expressing angiogenesis suppressor factor and its configuring process |
| 02/19/2003 | CN1397564A Mutant of human tissue type plasminogen activator |
| 02/19/2003 | CN1397563A Process for preparing phytolaccae antivirus protein |
| 02/19/2003 | CN1101937C Methodology for selecting superagonists, antagonists and superantagonist of hormones whose receptor complex includes GP 130 |
| 02/19/2003 | CN1101854C G protein coupled receptor protein, prodn. and use thereof |
| 02/19/2003 | CN1101823C Shark liver irritant for preventing and treating hepatism and its prepn. process |
| 02/19/2003 | CA2463490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/18/2003 | US6521816 Nucleic acid molecules from rice and their use for the production of modified starch |
| 02/18/2003 | US6521814 Use of ligands for treatment of diseases responsive to retinoids |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521749 GL50 nucleic acids and uses therefor |
| 02/18/2003 | US6521747 Haplotypes of the AGTR1 gene |
| 02/18/2003 | US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity |
| 02/18/2003 | US6521745 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| 02/18/2003 | US6521744 Binding or complexing oligomers through hydrogen bondin, van der Waals interaction, pi stacking or condensation |
| 02/18/2003 | US6521742 Human endokine alpha |
| 02/18/2003 | US6521741 Catalytic antibodies and a method of producing same |
| 02/18/2003 | US6521740 Expression vectors; genetic engineering |
| 02/18/2003 | US6521739 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |
| 02/18/2003 | US6521738 Method for making insulin precursors and insulin precursor analogs |
| 02/18/2003 | US6521737 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/18/2003 | US6521602 Anti-neoplastic compositions and uses thereof |
| 02/18/2003 | US6521598 Peptide consisting of an amino acid sequence 1: SPSVDKARAEL; induces transplant tolerance |
| 02/18/2003 | US6521596 Lanthionine antibiotic compositions and method |
| 02/18/2003 | US6521594 Method and composition for treating thrombosis |
| 02/18/2003 | US6521593 Using antagonists of integrins such as alpha v beta 3 and alpha v beta 5; inhibiting angiogenesis and vitronectin and tenascin mediated cell adhesion; inducing apoptosis |
| 02/18/2003 | US6521590 Amino acid sequence containing cysteine/glycine domain of chitin binding plant proteins; better activity against pathogenic fungi; transgenic plants expressing the protein show increased disease resistance |
| 02/18/2003 | US6521457 Lentivirus-based gene transfer vectors |
| 02/18/2003 | US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders |
| 02/18/2003 | US6521455 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 02/18/2003 | US6521454 Baculoviruses, insecticidal compositions, and methods for control of invertebrates |
| 02/18/2003 | US6521453 Oligonucloetide mediated nucleic acid recombination |
| 02/18/2003 | US6521450 Cells expressing a modified regulator of complement activation |
| 02/18/2003 | US6521448 Porcine MHC class I genes and uses thereof |
| 02/18/2003 | US6521442 Polynucleotide compositions encoding broad spectrum δ-endotoxins |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521440 Proteases from gram-positive organisms |
| 02/18/2003 | US6521438 Chemoreceptors in plant parasitic nematodes |
| 02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
| 02/18/2003 | US6521424 Recombinant expression of Tek antagonists |
| 02/18/2003 | US6521423 Intracellular production of Hepatitis C E2 polypeptides |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521420 Gene expression; diagnosing high blood pressure |
| 02/18/2003 | US6521419 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 02/18/2003 | US6521418 G protein-coupled receptor with an enlarged extracellular domain |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521410 Mutant of tissue factor pathway inhibitor, DNA sequence and use for detecting thrombotic disorders |
| 02/18/2003 | US6521409 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 02/18/2003 | US6521407 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors |
| 02/18/2003 | US6521406 From Saccharopolyspora; genetic engineering |
| 02/18/2003 | US6521405 Cell-free replication system and uses thereof |
| 02/18/2003 | US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface |
| 02/18/2003 | US6521403 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 02/18/2003 | US6521236 Vector vaccine of recombinant feline herpesvirus |
| 02/18/2003 | US6521235 Alphavirus RNA replicon systems |
| 02/18/2003 | US6521234 NL3 TIE ligand homologue |
| 02/18/2003 | US6521233 DNA sequence codes for polypeptides having collagen domain peptide amino acid sequences capable of dimerization or oligomerization; fusion proteins |
| 02/18/2003 | US6521232 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 02/18/2003 | US6521231 Pseudorabies virus protein |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | US6521229 41 kDa Cryptosporidium parvum oocyst wall protein |
| 02/18/2003 | US6521228 Monoclonal antibodies having preferential binding to human tumor necrosis factor related apoptosis inducing ligand(TRAIL) polypeptides; cytokines used as anticarcinogenic agents |
| 02/18/2003 | US6521227 Monoclonal or polyclonal antibodies having preferential binding to polypeptides used as prostate specific antigens |